World Health Organization. Obesity and overweight. Available online: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. Accessed on 25 January 2022.
Abdelaal M, le Roux CW, Docherty NG. Morbidity and mortality associated with obesity. Ann Transl Med. 2017;5(7):161.
Article PubMed PubMed Central Google Scholar
Nakamura K, Fuster JJ, Walsh K. Adipokines: a link between obesity and cardiovascular disease. J Cardiol. 2014;63(4):250–9.
Matsuzawa Y. Therapy insight: adipocytokines in metabolic syndrome and related cardiovascular disease. Nat Clin Pract Cardiovasc Med. 2006;3(1):35–42.
Article CAS PubMed Google Scholar
Wang Y, Chen D, Zhang Y, Wang P, Zheng C, et al. Novel adipokine, FAM19A5, inhibits neointima formation after injury through sphingosine-1-phosphate receptor 2. Circulation. 2018;138(1):48–63.
Article CAS PubMed Google Scholar
Lee Y-B, Hwang H-J, Kim JA, Hwang SY, Roh E, et al. Association of serum FAM19A5 with metabolic and vascular risk factors in human subjects with or without type 2 diabetes. Diab Vasc Dis Res. 2019;16(6):530–8.
Article CAS PubMed Google Scholar
Ali Yari F, Shabani P, Karami S, Sarmadi N, Poustchi H, et al. Circulating levels of FAM19A5 are inversely associated with subclinical atherosclerosis in non-alcoholic fatty liver disease. BMC Endocr Disord. 2021;21(1):153.
Wang W, Li T, Wang X, Yuan W, Cheng Y, et al. FAM19A4 is a novel cytokine ligand of formyl peptide receptor 1 (FPR1) and is able to promote the migration and phagocytosis of macrophages. Cell Mol Immunol. 2015;12(5):615–24.
Chen L, Chen R, Wang H, Liang F. Mechanisms linking inflammation to insulin resistance. Int J Endocrinol. 2015;2015:508409.
Cefalu WT. Inflammation, insulin resistance, and type 2 diabetes: back to the future? Diabetes. 2009;58(2):307–8.
Article CAS PubMed PubMed Central Google Scholar
Khan UI, Wang D, Sowers MR, Mancuso P, Everson-Rose SA, et al. Race–ethnic differences in adipokine levels: the Study of Women’s Health Across the Nation (SWAN). Metabolism. 2012;61(9):1261–9.
Article CAS PubMed PubMed Central Google Scholar
Hosseinpanah F, Barzin M, Mirbolouk M, Abtahi H, Cheraghi L, et al. Lipid accumulation product and incident cardiovascular events in a normal weight population: Tehran Lipid and Glucose Study. Eur J Prev Cardiol. 2016;23(2):187–93.
Han L, Fu K-L, Zhao J, Wang Z-H, Tang M-X, et al. Visceral adiposity index score indicated the severity of coronary heart disease in Chinese adults. Diabetol Metab Syndr. 2014;6(1):1–6.
Lee EY, Yang HK, Lee J, Kang B, Yang Y, et al. Triglyceride glucose index, a marker of insulin resistance, is associated with coronary artery stenosis in asymptomatic subjects with type 2 diabetes. Lipids Health Dis. 2016;15(1):1–7.
Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S, et al. Visceral adiposity index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010;33(4):920–2.
Article PubMed PubMed Central Google Scholar
Xia C, Li R, Zhang S, Gong L, Ren W, et al. Lipid accumulation product is a powerful index for recognizing insulin resistance in non-diabetic individuals. Eur J Clin Nutr. 2012;66(9):1035–8.
Article CAS PubMed Google Scholar
Kim TJ, Kim HJ, Kim YB, Lee JY, Lee HS, et al. Comparison of surrogate markers as measures of uncomplicated insulin resistance in Korean adults. Korean J Fam Med. 2016;37(3):188–96.
Article CAS PubMed PubMed Central Google Scholar
McAuley KA, Williams SM, Mann JI, Walker RJ, Lewis-Barned NJ, et al. Diagnosing insulin resistance in the general population. Diabetes Care. 2001;24(3):460–4.
Article CAS PubMed Google Scholar
Straczkowski M, Stepien A, Kowalska I, Kinalska I. Comparison of simple indices of insulin sensitivity using the euglycemic hyperinsulinemic clamp technique. Medical science monitor. Int Med J Exp Clin Res. 2004;10(8):CR480-4.
Semlitsch T, Stigler FL, Jeitler K, Horvath K, Siebenhofer A. Management of overweight and obesity in primary care—a systematic overview of international evidence-based guidelines. Obes Rev. 2019;20(9):1218–30.
Article PubMed PubMed Central Google Scholar
Donnelly JE, Blair SN, Jakicic JM, Manore MM, Rankin JW, American College of Sports Medicine Position Stand, et al. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc. 2009;41(2):459–71.
Oppert JM, Bellicha A, van Baak MA, Battista F, Beaulieu K, et al. Exercise training in the management of overweight and obesity in adults: synthesis of the evidence and recommendations from the European Association for the Study of Obesity Physical Activity Working Group. Obes Rev. 2021;22:e13273.
Article PubMed PubMed Central Google Scholar
Morze J, Rücker G, Danielewicz A, Przybyłowicz K, Neuenschwander M, et al. Impact of different training modalities on anthropometric outcomes in patients with obesity: a systematic review and network meta-analysis. Obes Rev. 2021;22(7): e13218.
Article PubMed PubMed Central Google Scholar
Codella R, Ialacqua M, Terruzzi I, Luzi L. May the force be with you: why resistance training is essential for subjects with type 2 diabetes mellitus without complications. Endocrine. 2018;62(1):14–25.
Article CAS PubMed Google Scholar
Shaw BS, Shaw I. Effect of resistance training on cardiorespiratory endurance and coronary artery disease risk: cardiovascular topics. Cardiovasc J S Afr. 2005;16(5):256–9.
Racil G, Zouhal H, Elmontassar W, Abderrahmane AB, De Sousa MV, et al. Plyometric exercise combined with high-intensity interval training improves metabolic abnormalities in young obese females more so than interval training alone. Appl Physiol Nutr Metab. 2016;41(1):103–9.
Article CAS PubMed Google Scholar
Mohammad Rahimi GR, Bijeh N, Rashidlamir A. Effects of exercise training on serum preptin, undercarboxylated osteocalcin and high molecular weight adiponectin in adults with metabolic syndrome. Exp Physiol. 2020;105(3):449–59.
Article CAS PubMed Google Scholar
Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Blood Press. 2009;18(6):308–47.
Article CAS PubMed Google Scholar
Bruce R. Exercise testing of patients with coronary artery disease. Ann Clin Res. 1971;3:323–32.
Balady GJ. ACSM’s guidelines for exercise testing and prescription. Am College Sports Med. 2000.
Brzycki M. Strength testing—predicting a one-rep max from reps-to-fatigue. J Phys Educ Recreat Dance. 1993;64(1):88–90.
Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502.
Article CAS PubMed Google Scholar
Mirmiran P, Bahadoran Z, Azizi F. Lipid accumulation product is associated with insulin resistance, lipid peroxidation, and systemic inflammation in type 2 diabetic patients. Endocrinol Metab (Seoul, Korea). 2014;29(4):443–9.
Wakabayashi I, Daimon T. A strong association between lipid accumulation product and diabetes mellitus in Japanese women and men. J Atheroscler Thromb. 2014;21(3):282–8.
Nascimento-Ferreira MV, Rendo-Urteaga T, Vilanova-Campelo RC, Carvalho HB, de Paz Oliveira G, et al. The lipid accumulation product is a powerful tool to predict metabolic syndrome in undiagnosed Brazilian adults. Clin Nutr. 2017;36(6):1693–700.
Article CAS PubMed Google Scholar
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28(7):412–9.
Article CAS PubMed Google Scholar
Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab. 2000;85(7):2402–10.
Article CAS PubMed Google Scholar
Lopes WA, Oliveira GHD, Locateli JC, Simões CF. TyG in insulin resistance prediction. Jornal de Pediatria. 2020;96(1):132–3.
Hopkins W, Marshall S, Batterham A, Hanin J. Progressive statistics for studies in sports medicine and exercise science. Med Sci Sports Exerc. 2009;41(1):3.
Zarzour A, Kim HW, Weintraub NL. Understanding obesity-related cardiovascular disease: it’s all about balance. Am Heart Assoc. 2018;138:64–6.
Mohammad Rahimi GR, AlizaeiYousefabadi H, Niyazi A, Mohammad Rahimi N, Alikhajeh Y. Effects of lifestyle intervention on inflammatory markers and waist circumference in overweight/obese adults with metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials. Biol Res Nurs. 2022;24(1):94–105.
Comments (0)